$1.485
-0.080 (-5.41%)收盘时
- High
- 1.600
- Open
- 1.570
- VWAP
- 1.52
- Vol
- 1.55M
- Mkt Cap
- —
- Low
- 1.466
- Amount
- 2.35M
- EV/EBITDA, TTM
- -0.72
Quantum Cyber N.V., formerly known as Mainz Biomed N.V., is a Germany‑based technology company engaged in the development of solutions in the fields of quantum computing and cybersecurity. The Company focuses on safeguarding digital infrastructure against emerging quantum‑related risks through technologies such as post‑quantum cryptography and defence‑related systems. Its activities include the development of applications supporting secure data protection and communication, as well as the establishment of a platform for quantum‑focused security technologies.
AI analysis of Quantum Cyber NV (QUCY)
buyMainz Biomed NV (QUCY) appears to be a good buy right now due to its recent strong performance, with a year-to-date change of +68.23% and a positive market reaction to significant orders worth $2.09 million. However, the main risk is the potential dilution from the CEO's $6 million investment, which could impact existing shareholders if he sells his shares.
估值指标
事件时间线
资讯
8.508-31NewsfilterQuantum Cyber Completes Installation of 3D Printing Drone Farm
- 5.008-25Newsfilter
Quantum Cyber Appoints New Head of U.S. Sales to Drive Commercialization
8.507-29GlobenewswireQuantum Cyber Releases Drone Supply Chain Framework
- 8.507-29Newsfilter
Quantum Cyber Releases Drone Supply Chain Framework
8.507-27GlobenewswireQuantum Cyber Completes First Mini-Interceptor Drone Production
QUCY FAQ — answered by Alphio AI
Quantum Cyber N.V., formerly known as Mainz Biomed N.V., is a Germany‑based technology company engaged in the development of solutions in the fields of quantum computing and cybersecurity. The Company focuses on safeguarding digital infrastructure against emerging quantum‑related risks through technologies such as post‑quantum cryptography and defence‑related systems. Its activities include the development of applications supporting secure data protection and communication, as well as the establishment of a platform for quantum‑focused security technologies. It operates in the Technology sector.
Mainz Biomed NV (QUCY) appears to be a good buy right now due to its recent strong performance, with a year-to-date change of +68.23% and a positive market reaction to significant orders worth $2.09 million. However, the main risk is the potential dilution from the CEO's $6 million investment, which could impact existing shareholders if he sells his shares.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。